Dr. Jay Chhablani

Faculty - Clinician, University of Pittsburgh UPMC Eye Center 203 Lothrop Street Pittsburgh,

5 articles

Jay Chhablani is a faculty-clinician at the University of Pittsburgh Eye Center. He completed clinical vitreo-retina fellowship from Sankara Nethralaya, Chennai, India. He was an International Council of Ophthalmology (ICO) fellow at Jules Gonin Eye Hospital, Switzerland, in 2009 and a Clinical Instructor at the Jacobs Retina Center at Shiley Eye Center, University of California, San Diego, USA (2010 to 2012) before he joined L V Prasad Eye Institute, Hyderabad, India as faculty (2012-19). His areas of interest are macular disorders and recent imaging techniques. He published more than 300 articles in peer-reviewed journals with specific emphasis in field of choroid. He is editor of books titles “Choroidal Disorders” and “Central Serous Chorioretinopathy”. He is on the reviewing boards of all high impact Ophthalmology journals. He is on the editorial board of several journals including American Journal of Ophthalmology. He is a member of Global ONE network committee of American Academy of Ophthalmology. He has won several national and international awards. He has delivered inaugural Ian Constable lecture at Asia-Pacific Vitreo-Retina Society in 2016. He received Inaugural Namperumalsamy Young Researcher Award in 2018 by Vitreo-Retina Society of India.

  1. Articles 2 Apr 2021 14 min read

    Advances in Retinal Imaging

    Modern imaging modalities in the field of the retina have expanded our understanding of common pathologies including diabetic retinopathy (DR), age-related macular degeneration (AMD), central serous chorioretinopathy (CSCR), and many rare retinal diseases such as dystrophies, which were poorly understood before. This chapter describes newer emerging techniques in retinal imaging which enables advanced screening, monitoring and provide objective measures for treatment monitoring. MULTICOLOUR IMAGING Compared to standard fundus cameras, multi-colour images produced by the scanning laser ophthalmoscope(SLO) have a higher resolution due to reduced light scatter and allow image acquisition at different planes and higher contrast through a non mydriatic pupil using different wavelengths. SPECTRALIS Optical Coherence Tomography SDOCT(SPECTRALIS SD-OCT, Heidelberg Engineering,Heidelberg, Germany) uses the confocal scanning laser ophthalmoscope(cSLO) to capture three simultaneous reflectance im

    Dr. Sushma J · Dr. Jay Chhablani
  2. Students Gallery 1 Apr 2021 5 min read

    How to Publish Your Thesis

    Although, thesis submission is a mandatory process for post-graduation, nonetheless, getting it published is an important step towards your career. After all the hard work of bringing the thesis, the next step should be to publish it. The idea of publishing should be clear even before you started the work. Why publish An unpublished work means that the work had never been done. If you wish to be in an academic position in the long-term and wish to be recognized among your colleagues, the best way is to publish your work. In the present era of fast communication and the internet, your works get cited more often, which builds your reputation across the world, in no time. The thesis methodology and literature review will often be outdated in 3-4 years from your thesis, therefore, don’t leave it too long to publish your thesis. Here are a few steps to follow to publish your thesis: Step 1. Before the start Before you decide your thesis topic, do a thorough literature search and propose new

    Dr. Jay Chhablani
  3. Articles 1 Apr 2021 11 min read

    Drug Induced Maculopathy: A Quick Look

    Generally all the drugs are likely to have some side effects. For ophthalmologists, it is essential to know the drugs which affect the vision or involve the eye as a part of their side-effects. This is a summary of the drugs causing damage to the posterior segment of the eye. Patterns of retinal toxicity: Disruption of the retina and retinal pigment epithelium Vascular damage Retinal folds Phenoithiazine Qunine sulfate Thioridazine Clofazimine Cholopromazine Deferoxamine Chloroquine derivatives Corticosteroid Chloroquine Cisplatin& carmustine Hydroxychloroquine Cisplatin & carmustine Qunine sulfate Aminogycoside Interferon Ergot derivatives Talc Phenylpropanolamine Oral contraceptives Cystoid macular edema Epinephrine Latanoprost Nicotinic acid Sulfa derivatives Hydroxychlorothiazide Acetazolamide Triamterene Metronidazole Chlorthalidone Crystalline retinopathy Uveitis Tamoxifen Talc Canthaxanthine Nitrofurantoin Methoxyflurane Rifabutin Cidofovir Miscellaneous Digoxin Methanol CHLOROQ

    Dr. Jay Chhablani
  4. Articles 1 Apr 2021 26 min read

    Optical Coherence Tomography

    Introduction Optical Coherence Tomography is a powerful noninvasive imaging modality that performs high resolution, micron-scale, cross-sectional imaging of the retina. Originally developed in 1991 by Huang et al, [1] OCT technology has continually evolved and expanded within ophthalmology and has been explored in a wide range of clinical applications. With the introduction of Spectral/ Fourier Domain OCT (SD-OCT, FD-OCT) and Swept Source OCT (SS-OCT), there is greater tissue resolving power, significantly higher scan density, and faster data acquisition than original Time Domain OCT. Thus, OCT has revolutionized the practice of ophthalmology and, in particular the diagnosis and management of patients with retinal disease. This chapter describes the basics of OCT technology and its clinical applications in retinal disorders. OCT technology and working principle [2-8] OCTs operate on the principle of indirect low-coherence interferometry, in which a beam of light is directed into the re

    Dr. Remya Paulose · Dr. Jay Chhablani
  5. Articles 5 Apr 2020 17 min read

    OCT in Age Related Macular Degeneration (ARMD) and Polypoidal Choroidal Vasculopathy (PCV)

    Optical Coherence tomography (OCT) has revolutionized the way we look at retinal disorders. The earliest version of OCT was the time domain OCT following which spectral domain OCT arrived. Advances such as enhanced depth imaging and swept source OCT have furthered our understanding of retinal disorders. Beginning from the early 90s , OCT has vastly improved the way we diagnose, prognosticate , treat and follow-up retinal disorders.(1) Why OCT? OCT has established itself as one the main imaging modalities in retinal conditions or macular disorders to be more specific. OCT is the most précised method measuring retinal thickness in-vivo.(1) Let us take age related macular degeneration (ARMD) as an example. Understanding the location of the neovascular membrane and its consequences such as intra/subretinal fluid can be clearly understood with the help of an OCT.(2) Prognostic factors such as integrity of the outer retinal layer , RPE alterations such as thickening or fragmentation and the

    Dr. Vishal Gowindhari · Dr. Jay Chhablani